Company intelligence / Profile preview

Inteligencia Capital

New York City, New York, United Statesinteligenciacapital.com ↗

Ownership: Private
Development stage: Other

Overview

Intelligencia AI offers an advanced platform that leverages clinical development data and artificial intelligence to help biopharmaceutical companies make better decisions about drug development risk, particularly around phase transitions. The company does not have its own clinical results as it is not a therapeutic developer but enables others to accelerate innovation for novel therapies through improved predictive analytics.

Therapeutic areas: Other
Modalities: Not directly developing therapeutics; provides data-driven decision support for drug development using artificial intelligence and clinical data analytics
Industry: Drug Discovery Services

Partnerships

Not specified in available sources; works broadly with biopharmaceutical companies as clients.

Beyond the preview

Go deeper on Inteligencia Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inteligencia Capital.

Explore the full profile